Invasive fungal infection is an important cause of mortality and morbidity in very preterm and very low birth weight infants. Early diagnosis is difficult and treatment is often delayed. Systemically absorbed antifungal agents (usually azoles) are increasingly used as prophylaxis against invasive fungal infection in this population.
Prophylactic systemic antifungal therapy reduces the incidence of invasive fungal infection in very preterm or very low birth weight infants. This finding should be interpreted and applied cautiously since the incidence of invasive fungal infection was very high in the control groups of many of the included trials. Meta-analysis does not demonstrate a statistically significant effect on mortality. There are currently only limited data on the long-term neurodevelopmental consequences for infants exposed to this intervention. In addition, there is a need for further data on the effect of the intervention on the emergence of organisms with antifungal resistance.
Facebook : PORT SAID EIGHTH NEONATOLOGY CONFERENCE 2017 SHARING STAFF: Prof Abla El Aalfy (Executive director of our dream project ) Prof Ahmed El Lawah (Alazhar univ) Prof Alaa Sobeih (Cairo univ) Prof Ahmed Amr Abbassy (Alexandria univ) Prof Atef Donia (Alazhar univ) Prof David Clark (USA) Dr.Elsayed Khalaf (Port Fouad hosp, Port…